Robert Kane is the chief operation officer and director for Cannabis Science, Inc., a U.S. biotech company focused on research and development of pharmaceutical-grade cannabis. He also serves as chief financial officer for Phytiva, the company’s line of over-the-counter nutraceuticals and cosmetics.
Early in his career, he worked as a registered representative for the financial firm, Ryan, Beck, & Company, later purchased by Stifel Nicolaus. In 2009, he left to start his own firm, Cannabis Consulting, Inc., where he advised medical cannabis industry leaders and specialized in business and management planning, as well as investor relations.
From there, his Kanabeis brand was born. The brand and consulting firm were acquired by Cannabis Science, Inc. in 2012, and Kane was kept on and embraced by the company in an investor relations role.
Kane’s mission is to transform the medical cannabis industry into a viable investment for all. He previously served as director of investor relations for Medical Marijuana, Inc., the first publicly traded medical marijuana company, and as CFO for Cannabiz Business University.
He also established the Medical Cannabis Index, or the MCANI, and blueprinted a private equity fund for medical marijuana companies, under his Kanabeis brand.
Kane studied economics and accounting at Elon University.
What is Robert James Kane's net worth?
The estimated net worth of Robert James Kane is at least $82,688.33 as of October 20th, 2016. Mr. Kane owns 16,537,665 shares of Cannabis Science stock worth more than $82,688 as of April 25th. This net worth evaluation does not reflect any other assets that Mr. Kane may own. Learn More about Robert James Kane's net worth.
How old is Robert James Kane?
How do I contact Robert James Kane?
The corporate mailing address for Mr. Kane and other Cannabis Science executives is 19800 Macarthur Blvd Ste 300, IRVINE, CA 92612-2479, United States. Cannabis Science can also be reached via phone at +1-888-8890888. Learn More on Robert James Kane's contact information.
Has Robert James Kane been buying or selling shares of Cannabis Science?
Robert James Kane has not been actively trading shares of Cannabis Science during the past quarter. Most recently, Robert James Kane sold 200,000 shares of the business's stock in a transaction on Wednesday, January 3rd. The shares were sold at an average price of $0.13, for a transaction totalling $26,000.00. Learn More on Robert James Kane's trading history.
